Back

Interaction of inherited genetic variants in the NLRP3 inflammasome/IL-6 pathway with acquired clonal hematopoiesis to modulate mortality risk in patients with HFrEF

27 August 2022 (16:15 - 16:40)
Organised by:
Congress Presentation Part of: Heart failure with reduced ejection fraction (HFpEF) Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Sebastian Cremer

Johann Wolfgang Goethe University, Frankfurt (Germany)

4 More presentations in this session

Presentation thumbnail
Prognostic value of left ventricular contractile reserve and heart rate reserve in dilated cardiomyopathy
Doctor Q. Ciampi (Benevento, IT)
Abstract Slides
Presentation thumbnail
Geographic variation in heart failure with reduced ejection fraction: Insights from the VICTORIA trial
Doctor J. Ezekowitz (Edmonton, CA)
Abstract Slides
Presentation thumbnail
Systolic blood pressure time in range and long-term clinical outcomes in patients with ischaemic cardiomyopathy
Mr G. Fu (Guangzhou, CN)
Abstract Slides
Presentation thumbnail
Peak oxygen consumption is associated with the inotropic reserve in patients with heart failure with reduced ejection fraction undergoing cardiopulmonary testing
Mr C. Fragoulis (Athens, GR)
Abstract Slides

Access the full session

Session thumbnail
Heart failure with reduced ejection fraction (HFpEF)

The Event

Event poster

ESC Congress 2022

27 August 2022 16:15 CET
You may be interested in
thumbnail
Webinar
Advanced heart failure therapy in HF patients with preserved and mildly reduced ejection fraction
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023
thumbnail
Congress Session
Transforming heart failure care: unlocking new pathways

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources